February 02, 2023 Sergey Brin's Off-the-Radar Foundation Is Huge — and Growing Fast. Here’s What We Know About It February 02, 2023/ Michael Kavate Sergey Brin’s foundation has nearly $5 billion in assets and a portfolio spanning Parkinson’s disease, science and activism. It’s not known for transparency, but we do know a fair amount about what it supports and why.Read More
September 15, 2022 Parkinson's Funders Take a Venture Philanthropy Approach to Speed Development of Treatments September 15, 2022/ Paul Karon The Parkinson's Foundation in the U.S. and Parkinson's U.K. have inked a new partnership to boost investment in treatments for the neurodegenerative condition that affects 10 million people worldwide.Read More
May 26, 2021 The Parkinson's Foundation Was Bracing for the Worst in 2020. Instead, Giving Surged May 26, 2021/ Paul Karon The Parkinson's Foundation granted $10 million more than expected, after 2020 proved to be a surprisingly strong year for fundraising. Here’s where the money is headed, and why donors and researchers have cause for optimism.Read More
October 06, 2020 "Aligning the Whole Chain." Behind a Sergey Brin-Funded Parkinson's Research Initiative October 06, 2020/ Paul Karon Aligning Science Across Parkinson's, a research initiative backed by Google co-founder Sergey Brin, recently announced its first round of grants. The effort aims to link up different threads of research and funding in the field.Read More
October 17, 2018 Payoff: Years of Investments in Parkinson’s Research is Yielding New Breakthroughs and Momentum October 17, 2018/ Alice Dickow It’s hard to overstate the importance of patient private funding in the battle against Parkinson’s. Grantmakers in it for the long haul have often been behind gains made against the disease, with such successes now coming at a faster clip. Read More
August 20, 2018 Where Are Grants Going in the Fight Against Parkinson's? August 20, 2018/ Alice Dickow About 60,000 new cases of Parkinson’s disease are diagnosed every year in the U.S. alone. We take a look at what two top research funders are doing to combat this disease.Read More